208 related articles for article (PubMed ID: 9179545)
1. The effect of vitamin C in high doses on plasma and biliary lipid composition in patients with cholesterol gallstones: prolongation of the nucleation time.
Gustafsson U; Wang FH; Axelson M; Kallner A; Sahlin S; Einarsson K
Eur J Clin Invest; 1997 May; 27(5):387-91. PubMed ID: 9179545
[TBL] [Abstract][Full Text] [Related]
2. Biliary lipid composition in patients with cholesterol and pigment gallstones and gallstone-free subjects: deoxycholic acid does not contribute to formation of cholesterol gallstones.
Gustafsson U; Sahlin S; Einarsson C
Eur J Clin Invest; 2000 Dec; 30(12):1099-106. PubMed ID: 11122325
[TBL] [Abstract][Full Text] [Related]
3. [Effects of vitamin C administration on cholesterol gallstone formation].
del Pozo R; Muñoz M; Dumas A; Tapia C; Muñoz K; Fuentes F; Maldonado M; Jüngst D
Rev Med Chil; 2014 Jan; 142(1):20-6. PubMed ID: 24861110
[TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholic acid treatment in cholesterol gallstone disease: effects on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity, biliary lipid composition, and plasma lipid levels.
Angelin B; Ewerth S; Einarsson K
J Lipid Res; 1983 Apr; 24(4):461-8. PubMed ID: 6854153
[TBL] [Abstract][Full Text] [Related]
5. Effect of the type of dietary fat on biliary lipid composition and bile lithogenicity in humans with cholesterol gallstone disease.
Yago MD; González V; Serrano P; Calpena R; Martínez MA; Martínez-Victoria E; Mañas M
Nutrition; 2005 Mar; 21(3):339-47. PubMed ID: 15797676
[TBL] [Abstract][Full Text] [Related]
6. Hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and biliary lipid composition in man: relation to cholesterol gallstone disease and effects of cholic acid and chenodeoxycholic acid treatment.
Ahlberg J; Angelin B; Einarsson K
J Lipid Res; 1981 Mar; 22(3):410-22. PubMed ID: 7240966
[TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholic acid treatment in humans: effects on plasma and biliary lipid metabolism with special reference to very low density lipoprotein triglyceride and bile acid kinetics.
Angelin B; Nilsell K; Einarsson K
Eur J Clin Invest; 1986 Apr; 16(2):169-77. PubMed ID: 3089812
[TBL] [Abstract][Full Text] [Related]
8. Serum and bile lipid levels in patients with and without gallstones.
Tang WH
J Gastroenterol; 1996 Dec; 31(6):823-7. PubMed ID: 9027646
[TBL] [Abstract][Full Text] [Related]
9. Bile and plasma lipid composition in non-obese normolipidemic subjects with and without cholesterol gallstones.
Halpern Z; Rubin M; Harach G; Grotto I; Moser A; Dvir A; Lichtenberg D; Gilat T
Liver; 1993 Oct; 13(5):246-52. PubMed ID: 8259036
[TBL] [Abstract][Full Text] [Related]
10. The relationship between serum lipids, nucleation time, and biliary lipids in patients with gallstones.
Janowitz P; Wechsler JG; Kuhn K; Kratzer W; Tudyka J; Swobodnik W; Ditschuneit H
Clin Investig; 1992 May; 70(5):430-6. PubMed ID: 1600355
[TBL] [Abstract][Full Text] [Related]
11. Low-dose ursodeoxycholic acid prolongs cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones.
Jüngst D; Brenner G; Pratschke E; Paumgartner G
J Hepatol; 1989 Jan; 8(1):1-6. PubMed ID: 2921499
[TBL] [Abstract][Full Text] [Related]
12. Effect of ursodeoxycholic acid on biliary bile acid and bile lipid composition in gallstone patients.
Stiehl A; Raedsch R; Rudolph G; Walker S
Hepatology; 1984; 4(1):107-11. PubMed ID: 6693062
[TBL] [Abstract][Full Text] [Related]
13. High level of deoxycholic acid in human bile does not promote cholesterol gallstone formation.
Gustafsson U; Sahlin S; Einarsson C
World J Gastroenterol; 2003 Jul; 9(7):1576-9. PubMed ID: 12854167
[TBL] [Abstract][Full Text] [Related]
14. Altered gallbladder concentration of biliary lipids during early cholesterol gallstone formation.
Roslyn JJ; Conter RL; DenBesten L
Dig Dis Sci; 1987 Jun; 32(6):609-14. PubMed ID: 3568948
[TBL] [Abstract][Full Text] [Related]
15. Effects of short-term treatment with pravastatin on the hepatic synthesis of cholesterol and bile acids in gallstone patients.
Hillebrant CG; Axelson M; Björkhem I; Wang FH; Nyberg B; Einarsson C
Eur J Clin Invest; 1998 Apr; 28(4):324-8. PubMed ID: 9615912
[TBL] [Abstract][Full Text] [Related]
16. Effects of pravastatin and ursodeoxycholic acid on cholesterol and bile acid metabolism in patients with cholesterol gallstones.
Okamoto S; Nakano K; Kosahara K; Kishinaka M; Oda H; Ichimiya H; Chijiiwa K; Kuroki S
J Gastroenterol; 1994 Feb; 29(1):47-55. PubMed ID: 8199696
[TBL] [Abstract][Full Text] [Related]
17. Effects of combined treatment with pravastatin and ursodeoxycholic acid on hepatic cholesterol metabolism.
Hillebrant CG; Nyberg B; Gustafsson U; Sahlin S; Björkhem I; Rudling M; Einarsson C
Eur J Clin Invest; 2002 Jul; 32(7):528-34. PubMed ID: 12153554
[TBL] [Abstract][Full Text] [Related]
18. Decreased protein concentration and improved metastability of bile induced by ursodeoxycholate.
Chijiwa K; Hirota I; Noshiro H
Gastroenterol Jpn; 1992 Feb; 27(1):88-94. PubMed ID: 1555751
[TBL] [Abstract][Full Text] [Related]
19. Biliary lipid output during three meals and an overnight fast. I. Relationship to bile acid pool size and cholesterol saturation of bile in gallstone and control subjects.
Northfield TC; Hofmann AF
Gut; 1975 Jan; 16(1):1-11. PubMed ID: 806491
[TBL] [Abstract][Full Text] [Related]
20. Gallstone formation in guinea pigs under different dietary conditions. Effect of vitamin C on bile acid pattern.
Bergman F; Curstedt T; Eriksson H; van der Linden W; Sjövall J
Med Biol; 1981 Apr; 59(2):92-8. PubMed ID: 7311630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
